144 related articles for article (PubMed ID: 37113722)
1. Prevalence and determinants of lymphedema in newly diagnosed Nigerian breast cancer patients using bioimpedance estimations.
Wuraola F; Olasehinde O; Di Bernardo M; Akinyemi P; Owoade I; Mohammed T; Aderounmu A; Ogunleye S; Adeleye A; Ogunyemi M; Knapp G; Kingham P; Alatise O
Ecancermedicalscience; 2023; 17():1506. PubMed ID: 37113722
[TBL] [Abstract][Full Text] [Related]
2. The role of bioimpedance spectroscopy method in severity and stages of breast cancer-related lymphedema.
Turgay T; Denkçeken T; Maralcan G
Turk J Surg; 2022 Mar; 38(1):11-17. PubMed ID: 35873745
[TBL] [Abstract][Full Text] [Related]
3. Prediction of treatment outcome with bioimpedance measurements in breast cancer related lymphedema patients.
Kim L; Jeon JY; Sung IY; Jeong SY; Do JH; Kim HJ
Ann Rehabil Med; 2011 Oct; 35(5):687-93. PubMed ID: 22506192
[TBL] [Abstract][Full Text] [Related]
4. Utilization of bioelectrical impedance analysis for detection of lymphedema in breast Cancer survivors: a prospective cross sectional study.
Lim SM; Han Y; Kim SI; Park HS
BMC Cancer; 2019 Jul; 19(1):669. PubMed ID: 31286884
[TBL] [Abstract][Full Text] [Related]
5. Determination of Bioelectrical Impedance Thresholds for Early Detection of Breast Cancer-related Lymphedema.
Liu S; Zhao Q; Ren X; Cui Y; Yang H; Wang S; Liu M; Wang S
Int J Med Sci; 2021; 18(13):2990-2996. PubMed ID: 34220327
[No Abstract] [Full Text] [Related]
6. Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
Kaufman DI; Shah C; Vicini FA; Rizzi M
Breast Cancer Res Treat; 2017 Dec; 166(3):809-815. PubMed ID: 28831632
[TBL] [Abstract][Full Text] [Related]
7. Comparison of perometry-based volumetric arm measurements and bioimpedance spectroscopy for early identification of lymphedema in a prospectively-screened cohort of breast cancer patients.
Gillespie TC; Roberts SA; Brunelle CL; Bucci LK; Bernstein MC; Daniell KM; Naoum GN; Miller CL; Taghian AG
Lymphology; 2021; 54(1):1-11. PubMed ID: 34506083
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging and bioimpedance evaluation of lymphatic abnormalities in patients with breast cancer treatment-related lymphedema.
Donahue PMC; Crescenzi R; Lee C; Garza M; Patel NJ; Petersen KJ; Donahue MJ
Breast Cancer Res Treat; 2020 Aug; 183(1):83-94. PubMed ID: 32601969
[TBL] [Abstract][Full Text] [Related]
9. Is bioimpedance spectroscopy a useful tool for objectively assessing lymphovenous bypass surgical outcomes in breast cancer-related lymphedema?
Sutherland A; Wagner JL; Korentager S; Butterworth J; Amin AL; Balanoff CR; Hangge A; Larson KE
Breast Cancer Res Treat; 2021 Feb; 186(1):1-6. PubMed ID: 33392840
[TBL] [Abstract][Full Text] [Related]
10. The Early Detection of Breast Cancer Treatment-Related Lymphedema of the Arm.
Keeley V
Lymphat Res Biol; 2021 Feb; 19(1):51-55. PubMed ID: 33270493
[No Abstract] [Full Text] [Related]
11. Acupuncture for breast cancer-related lymphedema: a randomized controlled trial.
Bao T; Iris Zhi W; Vertosick EA; Li QS; DeRito J; Vickers A; Cassileth BR; Mao JJ; Van Zee KJ
Breast Cancer Res Treat; 2018 Jul; 170(1):77-87. PubMed ID: 29520533
[TBL] [Abstract][Full Text] [Related]
12. The Impact of L-Dex(®) Measurements in Assessing Breast Cancer-Related Lymphedema as Part of Routine Clinical Practice.
Laidley A; Anglin B
Front Oncol; 2016; 6():192. PubMed ID: 27656420
[TBL] [Abstract][Full Text] [Related]
13. Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions.
Kilgore LJ; Korentager SS; Hangge AN; Amin AL; Balanoff CR; Larson KE; Mitchell MP; Chen JG; Burgen E; Khan QJ; O'Dea AP; Nye L; Sharma P; Wagner JL
Ann Surg Oncol; 2018 Oct; 25(10):2948-2952. PubMed ID: 29987599
[TBL] [Abstract][Full Text] [Related]
14. A Low-Cost, Portable, and Mobile-Based Bioimpedance Lymphedema Diagnosis and Monitoring System (Mobilymph): A Validation Study.
Syed Ibrahim SA; Ibrahim F; Taib NAM; Cho J
Lymphat Res Biol; 2023 Oct; 21(5):463-468. PubMed ID: 37093011
[No Abstract] [Full Text] [Related]
15. Upper extremity bioimpedance before and after treadmill testing in women post breast cancer treatment.
Smoot B; Zerzan S; Krasnoff J; Wong J; Cho M; Dodd M
Breast Cancer Res Treat; 2014 Nov; 148(2):445-53. PubMed ID: 25338320
[TBL] [Abstract][Full Text] [Related]
16. Reference values of bioelectrical impedance analysis for detecting breast cancer-related lymphedema.
Jung M; Jeon JY; Yun GJ; Yang S; Kwon S; Seo YJ
Medicine (Baltimore); 2018 Nov; 97(44):e12945. PubMed ID: 30383644
[TBL] [Abstract][Full Text] [Related]
17. Assessment of breast cancer-related lymphedema: a comparison of moisture meter and spot bioimpedance measurement.
Czerniec SA; Ward LC; Kilbreath SL
Lymphat Res Biol; 2015 Mar; 13(1):10-9. PubMed ID: 25667950
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention.
Koelmeyer LA; Gaitatzis K; Dietrich MS; Shah CS; Boyages J; McLaughlin SA; Taback B; Stolldorf DP; Elder E; Hughes TM; French JR; Ngui N; Hsu JM; Moore A; Ridner SH
Cancer; 2022 Sep; 128(18):3408-3415. PubMed ID: 35797441
[TBL] [Abstract][Full Text] [Related]
19. The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements.
Shah C; Zambelli-Weiner A; Delgado N; Sier A; Bauserman R; Nelms J
Breast Cancer Res Treat; 2021 Feb; 185(3):709-740. PubMed ID: 33245458
[TBL] [Abstract][Full Text] [Related]
20. Normative Interlimb Impedance Ratios: Implications for Early Diagnosis of Uni- and Bilateral, Upper and Lower Limb Lymphedema.
Steele ML; Janda M; Vagenas D; Ward LC; Cornish BH; Box R; Gordon S; Matthews M; Poppitt SD; Plank LD; Yip W; Rowan A; Reul-Hirche H; Obermair A; Hayes SC
Lymphat Res Biol; 2018 Dec; 16(6):559-566. PubMed ID: 30280970
[No Abstract] [Full Text] [Related]
[Next] [New Search]
